Drug-resistant tuberculosis: A worldwide epidemic poses a new challenge;Resistente tuberkulose: Große herausforderung durch eine weltepidemie

Deutsches Arzteblatt

Volumn 107, Issue 1-2, 2010, Pages 10-19

  Loddenkemper, Robert ^a   Hauer, Barbara ^a  

^a Deutsches Zentralkomitee Zur Bekämpfung der Tuberkulose ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG RESISTANT TUBERCULOSIS; EPIDEMIC; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77749310853     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2010.0010     Document Type: Article

References (25)

1. World Health Organization: Anti-tuberculosis drug resistance in the world. Report No. 4, 2008. WHO/HTM/TB/2008.394
2. World Health Organization: Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008. WHO/HTM/TB/2008.402
3. Robert Koch-Institut: Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2007. Robert Koch-Institut 2009, Berlin www.rki.de
4. World Health Organization: Global tuberculosis control: epidemiology, strategy, financing. WHO, Geneva, Switzerland, WHO/HTM/TB/2009.411
5. Eker B, Orzmann J, Migliori GB, et al.: Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis 2008; 14: 1700-6.
6. Cohen T, Colijn C, Wright A, Zignol M, Pym A, Murray M: Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med 2008; 177: 1302-6.
7. Loddenkemper R, Sagebiel D, Brendel A: Strategies against multidrug-resistant tuberculosis. Eur Respir J 2002; 20(Suppl 36): 66-77.
8. French CE, Glynn JR, Kruijshaar ME, Ditah IC, Delpech V, Abubakar I: The association between HIV and antituberculosis drug resistance. Eur Respir J 2008; 32: 718-25.
9. WHO Regional Office for Europe: Status paper on prisons and tuberculosis, WHO Kopenhagen, Dänemark 2007. EUR/07/5063912
10. Nunn P, Reid A, De Cock KM: Tuberculosis and HIV infection: the global setting. J Infect Dis 2007;196: 5-14.
11. Gandhi NR, Moll A, Sturm AW, Pawinski R, et al.: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-80.
12. Rüsch-Gerdes S, Hillemann D: Moderne mykobakteriologische Labor-diagnostik. Pneumologie 2008; 62: 533-40.
13. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose: Richtlinien zur medikamentösen Behandlung der Tuberkulose im Erwachsenen-und Kindesalter. Pneumologie 2001; 33: 494-511.
14. Caminero JA: Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006; 10: 829-37.
15. Blaas SH, Mütterlein R, Weig J, et al.: Extensively drug resistant tuberculosis in a high income country: A report of four unrelated cases. BMC Infect Dis 2008; 8: 60.
16. Kwon YS, Kim YH, Suh GY, et al.: Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. CID 2008; 47: 496-502.
17. Mitnick CD, Shin SS, Seung KJ, et al.: Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-74.
18. Kim DH, Kim HJ, Park S-K, et al.: Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008; 178: 1075-82.
19. World Health Organization: The Stop TB Strategy. Building on and enhancing DOTS to meet the TB-related Millenium Development Goals. World Health Organization, Geneva 2006. WHO/HTM/STB/2008
20. Floyd K, Pantoja A: Financial resources required for tuberculosis control to achieve global targets set for 2015. Bull World Health Organ 2008; 86: 568-76.
21. Migliori GB, Loddenkemper R, Blasi F, Raviglione MC: 125 years after Robert Koch's discovery of the tubercle bacillus: Is "science" enough to tackle the epidemic? Eur Respir J 2007; 29: 423-7.
22. Raviglione MC, Uplekar MW: WHO's new Stop TB Strategy. Lancet 2006; 367: 952-5.
23. World Health Organization: Guidelines for establishing DOTS-Plus projects for the management of multidrug-resistant tuberculosis (MDR-TB). World Health Organization, WHO/CDS/TB/2000.278. Geneva, Schweiz 2000.
24. Spigelman MK: New tuberculosis therapeutics: A growing pipeline. JID 2007; 196: S28-34.
25. Baumann S, Eddine AN, Kaufmann SHE: Progress in tuberculosis vaccine development. Curr Opin Immunol 2006; 18: 438-48.